When.com Web Search

  1. Ads

    related to: ulcerative colitis clinical guidelines

Search results

  1. Results From The WOW.Com Content Network
  2. Ulcerative colitis - Wikipedia

    en.wikipedia.org/wiki/Ulcerative_colitis

    The clinical presentation of ulcerative colitis depends on the extent of the disease process. [16] Up to 15% of individuals may have severe disease upon initial onset of symptoms. [ 12 ] A substantial proportion (up to 45%) of people with a history of UC without any ongoing symptoms (clinical remission) have objective evidence of ongoing ...

  3. Management of ulcerative colitis - Wikipedia

    en.wikipedia.org/wiki/Management_of_ulcerative...

    Management of ulcerative colitis involves first treating the acute symptoms of the disease, then maintaining remission. Ulcerative colitis is a form of colitis , a disease of the intestine , specifically the large intestine or colon , that includes characteristic ulcers , or open sores, in the colon.

  4. FDA-approved drug for ulcerative colitis also effective for ...

    www.aol.com/fda-approved-drug-ulcerative-colitis...

    Mirikizumab, a drug currently approved by the Food and Drug Administration (FDA) for the treatment of ulcerative colitis, also sends Crohn's disease into clinical remission, new findings suggest.

  5. Inflammatory bowel disease - Wikipedia

    en.wikipedia.org/wiki/Inflammatory_bowel_disease

    For ulcerative colitis, there is low-certainty evidence that probiotic supplements may increase the probability of clinical remission. [95] People receiving probiotics were 73% more likely to experience disease remission and over 2x as likely to report improvement in symptoms compared to those receiving a placebo, with no clear difference in ...

  6. Simple clinical colitis activity index - Wikipedia

    en.wikipedia.org/wiki/Simple_clinical_colitis...

    The Simple Clinical Colitis Activity Index (SCCAI) is a diagnostic tool and questionnaire used to assess the severity of symptoms in people who suffer from ulcerative colitis. It was created in 1998 and is still used to assess the severity of symptoms. [ 1 ]

  7. Vedolizumab - Wikipedia

    en.wikipedia.org/wiki/Vedolizumab

    Vedolizumab, sold under the brand name Entyvio, is a monoclonal antibody medication developed by Takeda Oncology for the treatment of ulcerative colitis and Crohn's disease. [5] It binds to integrin α 4 β 7 ( LPAM-1 , lymphocyte Peyer's patch adhesion molecule 1, a dimer of Integrin alpha-4 and Integrin beta-7 ), [ 5 ] [ 6 ] blocking the α 4 ...

  1. Ads

    related to: ulcerative colitis clinical guidelines